These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 38967113)
1. Evaluation of secretome biomarkers in glioblastoma cancer stem cells: A bioinformatics analysis. Jangholi E; Tehran HA; Ghasemi A; Hoseinian M; Firoozi S; Ghodsi SM; Tamaddon M; Bereimipour A; Hadjighassem M Cancer Rep (Hoboken); 2024 Jul; 7(7):e2080. PubMed ID: 38967113 [TBL] [Abstract][Full Text] [Related]
2. Bioinformatics and machine learning methodologies to identify the effects of central nervous system disorders on glioblastoma progression. Rahman MH; Rana HK; Peng S; Hu X; Chen C; Quinn JMW; Moni MA Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33406529 [TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma. Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538 [TBL] [Abstract][Full Text] [Related]
4. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis. Chen X; Pan Y; Yan M; Bao G; Sun X Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990 [TBL] [Abstract][Full Text] [Related]
5. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells. Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306 [TBL] [Abstract][Full Text] [Related]
6. SLC12A5 as a novel potential biomarker of glioblastoma multiforme. Chen J; Wang H; Deng C; Fei M Mol Biol Rep; 2023 May; 50(5):4285-4299. PubMed ID: 36917367 [TBL] [Abstract][Full Text] [Related]
7. Computational analysis and verification of molecular genetic targets for glioblastoma. Xue L; Liu H; Chen Y; Wei L; Hong J Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32469390 [TBL] [Abstract][Full Text] [Related]
8. PBK as a Potential Biomarker Associated with Prognosis of Glioblastoma. Dong C; Fan W; Fang S J Mol Neurosci; 2020 Jan; 70(1):56-64. PubMed ID: 31617063 [TBL] [Abstract][Full Text] [Related]
9. Identification of novel prognostic targets in glioblastoma using bioinformatics analysis. Yin X; Wu Q; Hao Z; Chen L Biomed Eng Online; 2022 Apr; 21(1):26. PubMed ID: 35436915 [TBL] [Abstract][Full Text] [Related]
10. Bioinformatics analysis of potential core genes for glioblastoma. Zhang Y; Yang X; Zhu XL; Hao JQ; Bai H; Xiao YC; Wang ZZ; Hao CY; Duan HB Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32667033 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of lncRNA-associated ceRNA network reveals novel potential prognostic regulatory axes in glioblastoma multiforme. Bazrgar M; Mirmotalebisohi SA; Ahmadi M; Azimi P; Dargahi L; Zali H; Ahmadiani A J Cell Mol Med; 2024 Jun; 28(11):e18392. PubMed ID: 38864705 [TBL] [Abstract][Full Text] [Related]
12. Identification of Potential Breast Cancer Stem Cell Biomarkers in the Secretome Using a Network Interaction Approach Analysis. Margaret AL; Wanandi SI; Fadilah F; Paramita RI Asian Pac J Cancer Prev; 2024 May; 25(5):1803-1813. PubMed ID: 38809653 [TBL] [Abstract][Full Text] [Related]
13. Association between SNAP25 and human glioblastoma multiform: a comprehensive bioinformatic analysis. Yu C; Yin J; Wang X; Chen L; Wei Y; Lu C; You Y Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32412599 [TBL] [Abstract][Full Text] [Related]
14. Hub biomarkers for the diagnosis and treatment of glioblastoma based on microarray technology. Cui K; Chen JH; Zou YF; Zhang SY; Wu B; Jing K; Li LW; Xia L; Sun C; Dong YL Technol Cancer Res Treat; 2021; 20():1533033821990368. PubMed ID: 34018447 [TBL] [Abstract][Full Text] [Related]
15. Multi-omics analysis predicts fibronectin 1 as a prognostic biomarker in glioblastoma multiforme. Kabir F; Apu MNH Genomics; 2022 May; 114(3):110378. PubMed ID: 35513291 [TBL] [Abstract][Full Text] [Related]
16. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion. Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832 [TBL] [Abstract][Full Text] [Related]
17. Autophagy-related CMTM6 promotes glioblastoma progression by activating Wnt/β-catenin pathway and acts as an onco-immunological biomarker. Dai L; Xiao J; Li X; Tao Y; Zhou P; Lyu L; Shi Z; Liang X; Jia Z; Jiang S J Gene Med; 2024 May; 26(5):e3685. PubMed ID: 38686653 [TBL] [Abstract][Full Text] [Related]
18. Quiescent stem cell marker genes in glioma gene networks are sufficient to distinguish between normal and glioblastoma (GBM) samples. Mukherjee S Sci Rep; 2020 Jul; 10(1):10937. PubMed ID: 32616845 [TBL] [Abstract][Full Text] [Related]
19. Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome. Binder ZA; Siu IM; Eberhart CG; Ap Rhys C; Bai RY; Staedtke V; Zhang H; Smoll NR; Piantadosi S; Piccirillo SG; Dimeco F; Weingart JD; Vescovi A; Olivi A; Riggins GJ; Gallia GL PLoS One; 2013; 8(10):e75945. PubMed ID: 24146797 [TBL] [Abstract][Full Text] [Related]
20. Construction of co-expression modules related to survival by WGCNA and identification of potential prognostic biomarkers in glioblastoma. Zhou J; Guo H; Liu L; Hao S; Guo Z; Zhang F; Gao Y; Wang Z; Zhang W J Cell Mol Med; 2021 Feb; 25(3):1633-1644. PubMed ID: 33449451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]